1st Quarter - Amendment

HELIX, INC. for HELIX, INC.

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 3, 2023 $40,000 Replaced
1st Quarter - Amendment (this page) Aug 3, 2023 $120,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Viral sequencing derived from blood and spital, viral surveillance and COVID-19 not limited to issues in US H1425 Senate Ratification of Pandemic World Health Organization Agreements, planning for FY24 budget, and Pandemic All Hazards Preparedness Reauthorization. Issues related to biomarker testing, hereditary cancers, and pharmacogenomics including US S708 Medicaid Coverage for Major Depressive Disorders.

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

COVID-19, other respiratory pathogen sequencing, including a comprehensive early warning network and countermeasure development in relation to Pandemic All Hazards Preparedness Act Reauthorization, express congressional authorization for FDA regulation of lab developed tests.

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES New —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Funding for viral sequencing (AMD, ASPR), data modernization, Center for Forecasting and Analytics and other non-specific programs to enhance interdepartmental communication on viral surveillance efforts, including considerations in the End the Threat of Default Act US-H415

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

Viral surveillance and viral sequencing, development of medical countermeasure for pathogens of pandemic potential

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Biosecurity efforts around viral surveillance and sequencing for known and unknown pathogens, intergovernmental cooperation on pathogens of pandemic potential

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.